Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1322-1327

  Rana, Obaida R ^a   Schröder, Jörg W ^b   Baukloh, Julia K ^b   Saygili, Esra ^a   Mischke, Karl ^b   Schiefer, Johannes ^c   Weis, Joachim ^b   Marx, Nikolaus ^b   Rassaf, Tienush ^a   Kelm, Malte ^a   Shin, Dong In ^a   Meyer, Christian ^a   Saygili, Erol ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; Modified Glasgow Outcome Score (MGOS); Neurofilament

Indexed keywords

ADRENALIN; LACTIC ACID;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN DAMAGE; COHORT ANALYSIS; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROFILAMENT; NEUROFILAMENT LIGHT CHAIN; OBSERVATIONAL STUDY; OUT OF HOSPITAL CARDIAC ARREST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RESUSCITATION;

CARDIAC ARREST; CARDIOPULMONARY RESUSCITATION; MODIFIED GLASGOW OUTCOME SCORE (MGOS); NEUROFILAMENT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NEUROFILAMENT PROTEINS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885313128     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.016     Document Type: Article

References (31)

1. ECC Committee, Subcommittees and Task Forces of the American Heart Association. American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care -part 3: overview of CPR. Circulation 2005;112:1-203.
2. Damian MS, Ellenberg D, Gildemeister R, et al. Coenzyme Q10 combined with mild hypothermia after cardiac arrest: a preliminary study. Circulation 2004;110:3011-6.
3. Turedi S, Gunduz A, Mentese A, et al. Investigation of the possibility of using Ischemia-modified albumin as a novel and early prognosticmarker In cardiac arrest patients after cardiopulmonary resuscitation. Resuscitation 2009;80:994-9.
4. Zandbergen EG, Hijdra A, Koelman JH, et al. Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology 2006;66:62-8.
5. Reisinger J, Höllinger K, Lang W, et al. Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase. Eur Heart J 2007;28:52-8.
6. Rana OR, Schröder JW, Kühnen JS, et al. The Modified Glasgow Outcome Score for the prediction of outcome In patients after cardiac arrest: a prospective clinical proof of concept study. Clin Res Cardiol 2012;101:533-43.
7. Shinozaki K,Oda S, Sadahiro T, et al. S-100B and neuron-specific enolase as predictors of neurological outcome In patients after cardiac arrest and return of spontaneous Circulation: a systematic review. Crit Care 2009;13:R121.
8. Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral Ischemia. Stroke 1998;29: 2363-6.
9. Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurological outcome after out-of hospital cardiac arrest: prediction by cerebrospinal fluid enzyme analysis. Arch Neurol 1989;46:753-6.
10. FogelW, Krieger D, VeithM, et al. Serumneuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 1997;25:1133-8.
11. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995;37:417-29.
12. Schäfer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996;21:134-40.
13. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999;1450:191-231.
14. Tullberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkelsö C. CSF neurofilament and glial fibrillary acidic protein In normal pressure hydrocephalus. Neurology 1998;50:1122-7.
15. Abe A, Numakura C, Saito K, et al. Neurofilament light chain polypeptide genemutations In Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype. J Hum Genet 2009;54:94-7.
16. Rosén H, Karlsson JE, Rosengren L. CSF levels of neurofilament Is a valuable predictor of long-term outcome after cardiac arrest. J Neurol Sci 2004;221:19-24.
17. Rana M, Schröder JW, Saygili E, et al. Comparative evaluation of the usability of 2 different methods to perform mild hypothermia In patients with out-of-hospital cardiac arrest. Int J Cardiol 2011;152:321-6.
18. Rana OR, Saygili E, Schiefer J,Marx N, Schauerte P. Biochemical markers and somatosensory evoked potentials In patients after cardiac arrest: the role of neurological outcome scores. J Neurol Sci 2011;305:80-4.
19. Meyer C, Heiss C, Drexhage C, et al. Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and Impairs vascular function. J Am Coll Cardiol 2010;55:454-9.
20. Zou KH, O'Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 2007;115:654-7.
21. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical consideration. Circulation 2006;113:2335-62.
22. Austin PC, Tu JV. Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial Infarction mortality. J Clin Epidemiol 2004;57:1138-46.
23. Janett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1: 480-4.
24. Rosengren LE, Karlsson JE, Karlsson JO, Persson Li, Wikkelsoø C. patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have Increased levels of neurofilament protein In CSF. J Neurochem 1996;67:2013-8.
25. Rosengren LE, Karlsson JE, Sjögren M, Blennow K, Wallin A. Neurofilament protein levels In CSF are Increased In dementia. Neurology 1999;52:1090-3.
26. Lycke J, Karlsson JE, Andersen O, Rosengren L. Neurofilament protein In cerebrospinal fluid: a potential marker of activity In multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64:402-4.
27. Blennow M, Savman K, Ilves P, Thoresen M, Rosengren L. Brainspecific proteins In the cerebrospinal fluid of severely asphyxiated newborn Infants. Acta Paediatr 2001;90:1171-5.
28. Böttiger BW, Möbes S, Glätzer R, et al. Astroglial protein S-100 Is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest In humans. Circulation 2001;103:2694-8.
29. Studahl M, Rosengren L, Gunther G, Hagberg L. Difference In pathogenesis between herpes simplex virus type 1 encephalitis and tickborne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J Neurol 2000;247:636-42.
30. Rundgren M, Friberg H, Cronberg T, Romner B, Petzold A. Serial soluble neurofilament heavy chain In plasma as a marker of brain Injury after cardiac arrest. Crit Care 2012;16:R45.
31. Steffen IG, Hasper D, Ploner CJ, et al. Mild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation: 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients. Crit Care 2010;14:R69.